Skip to content

Author

Antonio Gutiérrez

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

Real-world evidence study of brentuximab vedotin retreatment in patients with cutaneous T-cell lymphoma in Europe.

In advanced cutaneous T-cell lymphoma (CTCL), allogeneic stem cell transplant is the only curative option, but many patients are ineligible and relapse after systemic therapy, requiring retreatment with prior therapies. Brentuximab vedotin (BV), an anti-CD30 monoclonal antibody drug conjugated with monomethyl auristati...

C. Mitteldorf, A. de Masson, M. Beylot-Barry et al. · 0 citations
Open access Oct 2026

EZH2 mutation status predicts inferior outcomes after bendamustine‐based immunochemotherapy in frontline follicular lymphoma: A GELTAMO multicenter validation study

Follicular lymphoma is the most common indolent lymphoma and next ‐ generation sequencing (NGS) studies have identified recurrent mutations in chromatin ‐ modifying genes ( KMT2D, CREBBP, and EZH2 ).

C. Martínez-Laperche, Pilar Lancho-Lavilla, Antonio Gutiérrez et al. · 0 citations
Review Open access Sep 2026

Impact of a lifestyle intervention on the quality of life of people living with and beyond cancer – a feasibility study

Lifestyle interventions can reduce treatment-related side effects, promote health and improve quality of life (QoL) in people living with and beyond cancer (PLWBC). However, few studies focus on diet, physical activity (PA) and mental health (MH) as an integrated intervention. This pilot feasibility study provide...

J. Wordsworth, L. Prohens, A. Estelrich et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.